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Background: Plasmodium ovale is one of the five malaria species infecting humans. Recent data have shown that
the name of this neglected species masks two distinct genotypes also called curtisi and wallikeri. Some authors
show that these species could be sympatric. These two subspecies are not differentiated by microscopy techniques
and malaria rapid diagnostic tests. This diagnostic defect is the result of low parasitaemia, antigenic polymorphism
and absence of antibodies performance and requires the use of sequencing techniques. An accurate and easy
discrimination detection method is necessary.
Methods: A new molecular assay was developed to easily identify the two genotypes of P. ovale. This tool allowed
the study of 90 blood samples containing P. ovale, confirmed by molecular biology techniques, which were
obtained from patients with imported malaria.
Results: The new marker was validated on well genotyped samples. The genotype of 90 P. ovale samples mainly
imported from the Ivory Coast and the Comoros Islands was easily and quickly realized. The distribution of the two
subspecies was described with a significant number of samples and showed that the two genotypes were present
in the studied countries.
Conclusion: This work confirms the presence of the two species in the same country for the first time, in the Ivory
Coast and the Comoros Islands. A better genotyping of P. ovale types may improve a better characterization of the
clinical pathophysiology for each.
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Plasmodium ovale is the third species, in case number,
of agents causing human malaria. It was first described
in 1922 [1]. It has been reported all over the subtropical
continents [2], but is commonly found in tropical Africa,
New Guinea, Indonesia and Philippines. Its prevalence
rate, probably underestimated, ranged from 0.5 to 10.5%
of all malaria cases in 2005 [3]. It is estimated that about
15 million people are infected by this parasite [4]. Its* Correspondence: d.parzy@free.fr
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reproduction in any medium, provided the orimportance is growing, due to the decrease in the inci-
dence of Plasmodium falciparum and the potential
interactions with the other malaria infections.
Plasmodium ovale is still sensitive to all anti-malarial
drugs, and it shares the particularity with Plasmodium
vivax to form latent stage in the liver, referred to as hyp-
nozoite. This original behaviour is responsible for the
late relapse of the parasite, with new febrile access with-
out recent events of exposure. These febrile episodes
may occur in intervals of time that can reach several
months or years [3,5] and which require a specific treat-
ment with primaquine for complete clearance, obtained
after several cures. Severe cases have rarely been
described, but could occur nonetheless [6,7].td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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sons, particularly due to a frequent low level of parasit-
aemia [8], and the errors of microscopic diagnosis with
other malarial species. The low level of parasitaemia is a
disadvantage for the RDT detection. The lack of sensitiv-
ity and specificity of rapid diagnostic tests (RDT), as no
specific monoclonal antibody yet available leads to poor
P. ovale identification. Furthermore, the Pan signal is
often ineffective for its detection. The failures of P. ovale
detection by RDT are well documented [9,10]. Genetic
variations based on P. ovale LDH polymorphism could
be involved in RDTs failure [11]. To overcome this diffi-
culty, diagnostic methods using molecular biology tech-
niques have been developed. However, few target genes
are known because the total sequence of the P. ovale
genome is not yet available.
Species-specific sequences within genes encoding
small subunit ribosomal RNA (SSU rRNA) have been
used as primers and have allowed discrimination be-
tween different malaria parasites through sequencing
[12]. Different sets of primers were successively designed
to improve the diagnosis, which illustrated the problem
caused by the two genotypes for the diagnostic of the P.
ovale subspecies [13]. Rougemont et al. developed a
real-time PCR (RT-PCR) assay, which can separately dis-
tinguish the four major Plasmodium species [14]. Re-
cently, another RT-PCR method was developed to
identify the rare species from a mixed infection [15,16].
Complementary molecular investigations allowed the
identification of a polymorphism within the P. ovale
sequences. Species identification by 18S RNA sequencing
split the samples into two groups, classic/variant type re-
spectively named Plasmodium ovale curtisi and Plasmo-
dium ovale wallikeri by Sutherland et al. [4,17,18]. Other
investigations have confirmed that by the sequencing of
nine other target genes [4,11,18-22] whose genes encod-
ing the lactate dehydrogenase (LDH) and the ookinete
surface protein. Further studies with a conventional PCR
or SYBR-Green real-time PCR method confirm the exist-
ence of the simultaneous presence of two subspecies in
Africa [21].
A molecular marker based on hydrolysis probe technol-
ogy was developed to quickly distinguish the two geno-
types. This technique was used to study samples from
countries for which less information were available, the
Ivory Coast and the Comoros Islands, and the link be-
tween RDTs failure and genotyping group was studied.
Methods
Samples
Plasmodium ovale samples were selected among previ-
ously characterized blood samples collected from 2005
to 2010 from patients hospitalized in France and
infected with imported malaria. The samples, collectedin EDTA or ACD tubes, were stored at 4°C and were
received within 24 to 48 hours. Thin blood films and
RDTs were immediately performed. After centrifugation,
sera and the red blood cells pellet were separated and
stored at −20°C until analysis. For each sample, identifi-
cation of the parasite species was performed by micros-
copy, immunochromatography and molecular biology. A
total of 90 samples containing P. ovale parasites were
retained for further study.
Species detection
Thin blood films were immediately stained by Giemsa to
identify parasite species. They were read at least 20 min
before to consider the smears as negative. RDT was per-
formed on all the symptomatic samples received. These
tests allowed Plasmodium species to be quickly identified.
Normally all tests used should detect P. ovale species in a
pan-species result, according to the manufacturer‘s in-
struction for use. From 2005 to 2008, Now malariaW
(Binax, UK) was used, replaced by Core MalariaW (Core
Diagnostics Ltd, UK) or PalutopW (Alldiag, Strasbourg,
France) since 2009. These RDTs detect ALDOLASE and
LDH antigen respectively in the P. ovale samples. All these
tests were performed according to the manufacturers’
instructions except for blood pipetting with a micropipette
(10 μl) for more reproducible results.
Molecular Plasmodium species detection
Parasite genomic DNA templates were isolated from
200 μl of frozen red blood cells pellet using the DNA
isolation KIT (QIA amp DNA mini kit, QIAgen, Hilden),
according to the manufacturer's instructions. The Plas-
modium species detection of P. ovale was performed
with primers Pos25S and Pos25R [GenBank:AB074973]
(Table 1) using SYBR green qPCR as previously
described [15]. Since 2010, malaria species samples were
determined by real-time PCR using TaqMan probes and
a set of primers specific to the same target genes
(Table 1).
Plasmodium ovale subspecies detection
The detection was carried out by sequencing the SSU
rRNA and/or Po-ldh. The primers P1F-Up and 18S R
(Table 1) from Win [19] bound the SSU rRNA sequence.
Po-ldh gene polymorphism was established by sequen-
cing the central fragment of the gene. Amplification was
carried out with primers LDHovD21 and LDHovC915
designed at the extremities of the Po-ldh sequence [Gen-
Bank AY486058]. The number in the primer indicates
the position of the 5' base from the coding start position
of the Pf-ldh sequence [PlasmoDB: PF3D7_134900]
(Table 1) [23].
The real-time TaqMan PCR (TqPCR) assays were per-
formed in a final volume of 20 μl containing 5 μl of
Table 1 Primers and probes used for sequencing and TqPCR quantification
Type Primer/Probe 5’ Fluorophore Sequence 3’ Quencher
sp Pf B GGCAAATAACTTTATCATAGAATTGAC







sp pPf FAM TACACTACCAACACATGGGGCTACAAGAGGT BHQ1
sp pPv HEX CATCTACGTGGACAACGGGCTCAACA BHQ1
sp pPo FAM TTATTGTCCTCTGGGTTTGGAACTTTGCC BHQ1
sp pPmal HEX ATTTTTTGCATCAACCTTTCTTCTAGCCC BHQ1
C/W POF ATAAACTATGCCGACTAGGTT
C/W POR ACTTTGATTTCTCATAAGGTACT
C/W pPOW HEX AATTCCTTTTGGAAATTTCTTAGATTG BHQ1
C/W pPOC FAM TTCCTTTCGGGGAAATTTCTTAGA BHQ1
seq P1F-Up TCCATTAATCAAGAACGAAAGTTAAG
seq 18S R TAATGATCCTTCCGCAGGTTCACC
seq LDH ov D21 GTTCTCGTTGGTCAGGAATGATA
seq LDH ov C915 GGCATCATCAAACATCTTCTTTTCT
For species detection (sp), sequencing (seq) or P .ovale genotyping (C for P. o. curtisi /W for P. o. wallikeri).
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Roche, Germany), 0.1 μM of probe and 0.8 μM of each
primer (Eurogentec, Belgium). The cycle conditions used
were as follows: one step at 95°C for 10 min, 45 cycles at
95°C for 10 sec and 60°C for 30 sec, and a final step at
40°C for 30 sec, with a constant ramp rate at 20°C/sec.
Fluorescence was read at the end of each cycle on Light-
CyclerW 2.0 device (Roche Applied Science, Mannheim,
Germany).
A sequence of the SSU rRNA gene was also used to
design a pair of primers named PoF and PoR and two
probes (pPOC and pPOW) (Table 1) for the TqPCR ana-
lysis (Table 2). A Clustal [24] alignment was made on
sequences from “malmai” [seq X99790] and “poc1”
[AB182489] for P. o. curtisi and P. o. wallikeri forms, re-
spectively [19]. Each probe is specific to one of the twoTable 2 Genotype determination by sequencing and POCPOW
Gene Type Sample (n = 70)
SSU rRNA curtisi 14
SSU rRNA wallikeri 9
LDH curtisi 30
LDH wallikeri 17
Samples were first identified by amplification of the SSU rRNA and ldh sequences, th
TqPCR results and the similarity was calculated. Four P. o. curtisi samples and four PP. ovale types and displays a distinct HEX or FAM
fluorochromes, with readings at 530 and 560 nm for
pPOW and pPOC, respectively. The primers, with a
Tm of 60°C, were designed by Primer ExpressWsoft-
ware v2.0, and the probes, with a Tm of 10 degrees
higher according to the TaqMan technology specifica-
tion, were manually designed. The probes were
designed to target a deletion at position 1158 in vari-
ant SSU rRNA sequence [19]. The TqPCR amplified
fragment is 118 bases. The pPOW probe contains the
deletion, present in all sequences of this type and the
pPOC probe was designed in the same place in the
classic sequence.
As positive control, DNA from well characterized sam-
ples of each P. ovale type was used. The efficiency of
each reaction was assessed using 10-fold dilutions of theassay
TqPCR





anks to the primers displayed below. The results were compared with the
















































Figure 1 Real-time amplification plot with POC marker (A) and
POW marker (B) of three samples of each, P. o. curtisi (black)
and P. o. wallikeri (white). Water line is negative control (grey
rhombus). Positive control (square). The X-axis: the cycle number
and the Y-axis: the fluorescence arbitrary unit (FU). Detection was
carried at 530 nm and at 560 nm for (A) and (B) respectively.
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the slope of standard curves generated by plotting
graphs of genomic DNA concentrations vs Ct values was
determined. The specificity was verified by using the
four other human malaria species DNA (P. falciparum,
P. vivax, Plasmodium malariae and Plasmodium know-
lesi) and human DNA as target template.
Results
Samples
The selection of blood samples from imported cases of
malaria patients mainly from the Ivory Coast and the
Comoros Islands, has allowed the study of 90 P. ovale
DNA samples. Species identification was previously per-
formed by microscopy observations and RDTs. The mo-
lecular method was used to confirm the species
diagnostic. However, these methods were not able to dis-
tinguish the P. ovale subtypes. This identification is pos-
sible by sequencing the 18S RNA gene or several coding
sequences previously published, but the delay to obtain
the result is long [19].
Marker set-up
This RT-PCR was set up on two reference samples,
defined as “classic” (Poc) and “variant” (Pov), according
to both LDH and SSU rRNA gene sequencing. The SSU
rRNA sequence polymorphisms are broadly used refer-
ences [12]. The P. ovale LDH (PoLDH) gene was
selected since the corresponding protein is detected in
RDT diagnosis and genetic variation in this protein was
suggested as a possible cause for RDT failure.
The efficiency of primers (named PoF and PoR) and
probes set (named pPOC for P. o. curtisi and pPOW for
P. o. wallikeri) has been determined in a specific assay.
The mean curve slope and coefficient correlation were
respectively −3.18 and 0.997 for the P. o. wallikeri type,
with corresponding mean reaction efficiency of 99.71%
and for the P. o. curtisi form, the mean curve slope and
coefficient of correlation were −3.28 and 0.997, respect-
ively, with a corresponding mean reaction efficiency of
99.77%. The sensitivity was tested with parasitaemia
dilutions of 0.0065% to 0.000065% (Ct of 27.16 and
33.35 respectively) for P. o. wallikeri, and 0, 01% to 0,
0001% (Ct of 27, 50 and 34, 00 respectively) for P. o.
curtisi.
These new sets of primers and probes are very specific,
and they did not cross with other malaria species or
human DNA.
Samples genotyping
The validation of these markers was made on 62 P. ovale
samples, previously characterized either their SSU rRNA
or ldh gene sequence (Table 2). The sequencing of the
central part of the ldh gene distinguished the twosubspecies thanks to the substitutions on the codon
positions S143P, 1N68K, previously describes, and I204V
for P. o. curtisi and P. o. wallikeri: respectively (Add-
itional file 1) [11,20].
Among the 62 samples, the sequencing of the ldh and
SSU rRNA genes has been done both for eight samples
and the new marker validate these results (Figure 1A
and 1B). The “POCPOW” markers were used to identify
the subspecies of remaining P. ovale samples. For all the
samples studied, 31 were determined as P. o. wallikeri
types and 59 as P. o. curtisi types (Additional file 2).
Co-existence of Plasmodium ovale populations
The determination of the genotype gave the opportunity
to study the country repartition of the two P. ovale sub-
species. The used samples came from different countries,
especially from Africa, with a predominant recruitment
from Ivory Coast and the Comoros Islands. In general
terms, the P. o. curtisi form is more widespread than the
P. o. wallikeri in studied sample. The P. o. curtisi form
represented 62.8% of samples and 37.1% belonging to
the P. o. wallikeri form (Table 2). In the Ivory Coast,
most of the samples were P. o. curtisi form (25/31
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Comoros Islands (11/18 samples) were of P. o. wallikeri
form. This distribution is statistically different (Chi2 test;
p = 0,031).
Parasitaemia level
Easy identification of the two subtypes allowed investiga-
tion of the behaviour of the two genotypes. The parasit-
aemia was established and validated in 63 samples by an
experienced microscopist. It was shown to be low ran-
ging from to 0 to 0.5% (Additional file 2).
The two population statistical analysis with Wilcoxon
test showed no parasitaemia level difference (Chi2 test
p = 0.3353).
RDT failure
Laboratory practice and literature reported that RDT
failure is often observed with P. ovale samples. This
RDT failure is currently hypothesized by the role of nat-
ural variability present in tested species, as well as by the
low parasitaemia often encountered. It was observed a
higher false negative rate for the P. o. curtisi than for the
P. o. wallikeri (about 60% vs 43% respectively). However,
due to the relatively small number of samples available
for each RDT and lot used, the difference was not statis-
tically significant. From these results, the three tests
used have the same efficiency with ALDOLASE or LDH
antigens detection. The false negative results rates for
the detection of P. o. curtisi with RDTs using ALDO-
LASE or LDH antigens were 60% and 63% respectively.
For the detection of P. o. wallikeri, the rate of false nega-
tive results was 43% no matter the antigen used by the
tests. The positive results rates for the detection of P. o.
curtisi with RDTs using ALDOLASE or LDH antigens
were 40% and 37% respectively and for P. o. wallikeri de-
tection, the positive results rates was 57% for the 2 anti-
gens used.
The other factor commonly associated with RDT fail-
ure is low parasitaemia level. In this study, there is no
influence of parasitaemia on RDT failure (Chi2 test
p = 0.4108). The result of the RDT based on LDH anti-
gen detection seems to be less affected by the low para-
sitaemia level than those detecting the aldolase antigen
(Chi2 test p = 0.9843 and Chi2 test p = 0.0314 without
the outlayer data of 0.5% respectively).
Discussion
The single microscopic diagnostic had for a long time
limited the description of human malaria to four species.
Microscopic diagnostic is an insufficient method to ac-
curately discriminate between the species [7,25], because
of its limited resolution, the morphological similarity of
certain Plasmodium species and, especially, the expertise
of the microscopist. In the same way, P. o. curtisi and P.o. wallikeri were confused due to their morphology.
Until recently, the molecular methods detected P. ovale
without distinguishing the subspecies. The consequence
is doubt in the epidemiological study due to a lack of
tools in the rare species diagnostic, such as P. ovale and
P. malariae, which are less known and in fact more diffi-
cult to be characterized [7]. A better understanding of
the circulating malaria species in the environment could
increase the success in the identification of the human
infectious species. For that, molecular methods have
been developed and now bring corresponding tools to
specifically identify each species or subspecies.
In this study, a rapid method has been developed to
distinguish the two P. ovale subspecies. A TaqMan tech-
nology was chosen because the probes provide greater
specificity. This method could be used to identify a co-
infection between P. o. curtisi and P. o. wallikeri. So,
these TaqMan markers with standard conditions could
be added to the set of other markers for the detection of
all species in one run. This method was clearly capable
of to distinguishing the two P. ovale forms.
Ten different genes have been used across the different
studies to characterize the 216 P. ovale samples.
[4,11,18-22]. Two sequences were obtained for each
gene and defined two groups of alleles without mixing.
The lack of recombination between these two groups of
gene supports the notion of separated species. This view
is in agreement with the results obtained by the sequen-
cing and the TqPCR.
In 2010, Sutherland described the distribution of the
two forms according to country origin [4]. The authors
demonstrated that P. ovale was divided into two non-
recombining sympatric species in Africa and Asia for 55
samples. To complete these data, the study of P. o. cur-
tisi and P. o. wallikeri in Africa, especially in the Ivory
Coast and in the Comoros Islands, was introduced. It
complete and deepen the knowledge of the distribution
of the two subspecies worldwide (Table 3).
The meta-analysis of all the data available indicates
that the two subspecies are present in several ana-
lysed countries. Nevertheless, more detailed studies
must be carried out to specify this data. By extrapola-
tion, two subpopulations are suspected to be present
in all countries where P. ovale rages if the data was
sufficient. Among all the samples included in the
study, no co-infection has been detected according
results of previous studies [4,21,22]. Recently only one
mixed infection of P. o. curtisi and P. o. wallikeri was
described [26].
One important question is the origin of this sympatry.
To explain that, Oguike [21] put forward a hypothesis of
the parasite’s evolution, the blood polymorphism host
group, or a different recognition of certain molecules
involved in the parasite cycle. Another hypothesis should
Table 3 Meta-analysis of P. ovale repartition
Countries P. ovale P. o. curtisi P.o. wallikeri Author
Ivory Coast 33 25 8 *
Ivory Coast 1 0 1 [4]
Cameroon 5 4 1 *
Cameroon 1 0 1 [4]
Benin 2 2 0 *
Benin 1 0 1 [4]
Ghana 1 0 1 [22]
Ghana 3 2 1 [4]
Uganda 3 1 2 [4]
Uganda 30 11 19 [21]
Uganda north 6 5 1 [21]
Congo 1 1 0 [4]
Congo Brazzaville 6 2 4 [21]
Nigeria 20 12 8 [4]
Comoros Islands 18 7 11 *
Thailand 10 0 10 [4]
Guinea-Bissau 4 4 0 [4]
Equatorial guinea 4 2 2 [21]
Sierra Leone 3 2 1 [4]
Sao tome 3 2 1 [4]
Chad 2 1 1 *
Burkina Faso 1 1 0 *
Sri-Lanka 1 1 0 *
Tanzania 1 1 0 [4]
Mozambique 1 1 0 [4]
Vietnam 1 0 1 [4]
Papua New Guinea 1 0 1 [4]
Bangladesh 24 11 13 *
Uncertain 1 1 0 [4]
Unknown 23 15 8 *
Multi-countries 5 3 2 *
Total * 90 59 31 *
Total 216 117 99 all
* This study.
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same area but at different periods of time. The human
malaria vectors being described and present in the Ivory
Coast and Comoros Islands are the same mosquitoes
species (Anopheles gambiae and Anopheles funestus)
[27,28]. The correlation between the different seasons
and the emergence of different malaria vectors should
be investigated. This point cannot be explained in this
study, because the number of samples is not large
enough and too disparate for a given country and a
given period of time. Furthermore, varied climatic zonesexist within the same country. In order to enlighten this
hypothesis, it would be necessary to collect the samples
from the same village at the same time. That would
allow the comparison of the subtype identification from
different climatic periods. Conversely, the repartition of
the P. ovale subspecies into the various populations of
Anopheles has never been investigated. This marker
would be a tool of choice for it.
The unique difference between the two subspecies was
the parasitaemia level. Indeed in one study, P. o. wallikeri
has been associated with higher levels of parasitaemia in
humans [17,18]. In this study, the both parasitaemia
averages are very low and similar. The low parasitaemia is
often evoked to explain the false negative results in RDT.
A recent statement on the eradication programme empha-
sizes the role of sensitive diagnostic and especially the role
of RDT and its lack of performance for neglected malaria,
which remains unavailable for the moment in the break-
down of the malaria effort. Nevertheless, the small cohorts
of P. ovale samples and the different RDT used in the lit-
erature make the comparisons difficult between the differ-
ent studies. The fact that the tests available poorly detect
P. ovale infection can be the consequence of the genetic
difference between the two populations. The RDT must
be improved in the light of the information. In the mean-
time, the specific Tq RT-PCR developed and described
here will strongly improve the determination and the
characterization of parasitaemia according to the P. ovale
subspecies.
The P. ovale species are considered as neglected. How-
ever, severe cases pertaining to acute respiratory symp-
toms have been reported [6,29-31]. Other severe cases
describe spleen rupture [32,33]. These cases have never
been the subject of molecular investigation to identify
the P. o. curtisi or the P. o. wallikeri subtype. Taking this
parameter into account would be helpful for the know-
ledge of clinical survey differences possibly existing be-
tween the two strains, which could further indicate
whether one of the two species is more aggressive. To
verify this hypothesis it will be necessary to upgrade this
genotyping tool onto a true molecular diagnostic to re-
place the former P. ovale marker.
Conclusion
The use of the specific primers and probes described
here could be a very accurate, useful, easy and rapid
method of genotyping two different P. ovale subspecies.
This technique will allow a better understanding of their
characteristics, their biology and their responsibility in
the clinical symptomatology. Molecular diagnostics are
therefore essential for this purpose.
This study, due to the analysis of a large number of
samples, confirms the presence of two subspecies in the
same country and increases the knowledge of the two
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nally the question of the existence of six Plasmodium
species infecting humans could be asked.
Additional files
Additional file 1: Alignment of PocLDH and PowLDH. Using PoLDH
(Genbank AY486058) as reference, obtained sequences for P. o. curtisi
(Poc_LDH) and P. o. wallikeri (Pow_LDH) were aligned in nucleotide (A)
and translated protein (B) with CLUSTAL 2.0.12 multiple sequence
alignment software. The Sequence PocLDH and PowLDH were obtained
from samples Po22 and Po23 respectively. In A, the reference sequence
AY486058 is related to P. o. curtisi. Differences in Pow sequences are box-
shaded in grey. In (B), the full sequence of Pf-pLDH protein was added
like another reference (Pf13_141). The amino-acid switch between Poc
and Pow sequences are indicated with their amino-acid number. All
other differences are box-shaded, conservative in grey and non-
conservative in white.
Additional file 2: Detail of the sequencing results per sample. The
genotyping result is indicated for each sample (P. o. curtisi (C) and P. o.
wallikeri (W)) with reference sequences obtained by ldh or SSuRNA and
results of POCPOW marker. Corresponding parasitaemia and RDT results
according to the antigen used are indicated. neg: RDT negative result;
pos: RDT positive result, T2: pan signal.
Abbreviations
IC: Ivory Coast; LDH: Lactate dehydrogenase; RDT: Rapid diagnostic test; SSU
rRNA: Small subunit ribosomal RNA; TqPCR: Real-time Taqman PCR.
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